Dendritic cell-derived exosomes as maintenance immunotherapy after first line chemotherapy in NSCLC-Reference-Cited by-同舟云学术

Dendritic cell-derived exosomes as maintenance immunotherapy after first line chemotherapy in NSCLC

Published:2015-08-12 Issue:4 Volume:5 Page:e1071008
ISSN:2162-402X
Container-title:OncoImmunology
language:en
Short-container-title:OncoImmunology

Author:

Besse Benjamin,Charrier Mélinda,Lapierre Valérie,Dansin Eric,Lantz Olivier,Planchard David,Le Chevalier Thierry,Livartoski Alain,Barlesi Fabrice,Laplanche Agnès,Ploix Stéphanie,Vimond Nadège,Peguillet Isabelle,Théry Clotilde,Lacroix Ludovic,Zoernig Inka,Dhodapkar Kavita,Dhodapkar Madhav,Viaud Sophie,Soria Jean-Charles,Reiners Katrin S.,Pogge von Strandmann Elke,Vély Frédéric,Rusakiewicz Sylvie,Eggermont Alexander,Pitt Jonathan M.,Zitvogel Laurence,Chaput Nathalie

Publisher

Informa UK Limited

Subject

Oncology,Immunology,Immunology and Allergy

Link

https://tandfonline.com/doi/pdf/10.1080/2162402X.2015.1071008

Reference41 articles.

1. Oncology Meets Immunology: The Cancer-Immunity Cycle

2. Harnessing the Power of the Immune System to Target Cancer

3. Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer

4. Dendritic Cell–Derived Exosomes as Immunotherapies in the Fight against Cancer

5. Regulation of immune responses by extracellular vesicles

Cited by 586 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exosome-based nanoparticles and cancer immunotherapy;Biomedicine & Pharmacotherapy;2024-10

2. Exosomes of immune cell origin and their therapeutic potential for tumors;VIEW;2024-09-02

3. Exosomes in esophageal cancer: Promising nanocarriers in cancer progression, diagnosis, prognosis, and therapy;WIREs Nanomedicine and Nanobiotechnology;2024-09

4. Recent advances to address challenges in extracellular vesicle-based applications for lung cancer;Acta Pharmaceutica Sinica B;2024-09

5. Cancer immunotherapy and its facilitation by nanomedicine;Biomarker Research;2024-08-03